Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)
Condition: Metastatic Castration Resistant Prostate Cancer Interventions: Drug: Rucaparib; Drug: Enzalutamide; Drug: Abiraterone Sponsor: Clovis Oncology, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials